Norfloxacino Stada (Norfloxacin)

Norfloxacino Stada is a fluoroquinolone antibiotic indicated for several bacterial infection categories.

• Uncomplicated urinary tract infection: eradicates susceptible Gram‑negative pathogens and relieves dysuria and frequency.
• Acute bacterial prostatitis: penetrates prostatic tissue to eliminate causative organisms.
• Traveler’s diarrhea (enteric infections): reduces duration and severity of gastrointestinal symptoms caused by susceptible bacteria.
• Gonococcal urethritis: provides effective bactericidal activity against Neisseria gonorrhoeae.
• Acute exacerbations of chronic bronchitis: helps control bacterial load in the lower respiratory tract.

• Norfloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By binding to these targets, it prevents DNA synthesis and transcription, leading to bacterial cell death. The drug exhibits concentration‑dependent bactericidal activity against a broad spectrum of Gram‑negative and some Gram‑positive organisms.

Norfloxacino Stada may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools, sometimes watery.
• Headache: transient cranial discomfort.
• Dizziness: sensation of light‑headedness.
• Rash: mild skin erythema or itching.
• Photosensitivity: increased sunburn risk.

Serious or Rare Side Effects

• Tendon rupture or tendinitis, especially in the Achilles tendon.
• QT interval prolongation leading to cardiac arrhythmias.
• Severe allergic reactions such as Stevens‑Johnson syndrome.
• Clostridioides difficile‑associated colitis.
• Hepatic dysfunction with elevated transaminases.
• Peripheral neuropathy presenting as tingling or numbness.

Before prescribing Norfloxacino Stada, clinicians should consider several safety factors.

• Renal impairment: assess kidney function and adjust dosing if necessary.
• History of tendon disorders: avoid use in patients with prior tendon injury.
• Concomitant QT‑prolonging agents: monitor cardiac rhythm closely.
• Pregnancy: reserve for situations where benefits outweigh potential fetal risk.
• Known hypersensitivity to fluoroquinolones: contraindicated.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Norfloxacino Stada can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: markedly reduce norfloxacin absorption.
• Warfarin: may potentiate anticoagulant effect, increasing bleeding risk.
• Theophylline: can raise serum theophylline concentrations, leading to toxicity.
• Corticosteroids: combined use raises the chance of tendon rupture.
• Cyclosporine: may increase cyclosporine plasma levels.

Moderate Interactions (Monitor Closely)

• NSAIDs: heightened risk of central nervous system adverse events.
• Oral hypoglycemic agents: possible alteration of blood glucose control.
• Oral contraceptives: reduced hormonal efficacy, consider backup contraception.
• Diabetic medications: monitor for hypoglycemia or hyperglycemia.
• Antidepressants (SSRIs): watch for additive QT prolongation.